基因页:PIAS1
概括?
基因ID | 8554 |
Symbol | PIAS1 |
同义词 | DDXBP1|GBP|GU/RH-II|ZMIZ3 |
描述 | protein inhibitor of activated STAT 1 |
参考 | MIM:603566|HGNC:HGNC:2752|HPRD:16029| |
基因type | protein-coding |
地图位置 | 15q |
Pascal P值 | 0.58 |
Sherlock P值 | 0.148 |
Fetal beta | 0.416 |
DMG | 1(#研究) |
数据源中的基因
基因集名称 | 基因组方法 | 描述 | Info |
---|---|---|---|
CV:GWASDB | 全基因组关联研究 | gwasdbrecords for schizophrenia | |
简历:PGCNP | Genome-wide Association Study | GWAS | |
DMG:Nishioka_2013 | Genome-wide DNA methylation analysis | The authors investigated the methylation profiles of DNA in peripheral blood cells from 18 patients with first-episode schizophrenia (FESZ) and from 15 normal controls. | 1 |
第一节遗传学和表观遗传学注释
Differentially methylated gene
探测 | Chromosome | Position | Nearest gene | P (dis) | beta(dis) | FDR (dis) | Study |
---|---|---|---|---|---|---|---|
CG06790275 | 15 | 68346669 | PIAS1 | -0.027 | 0.57 | DMG:Nishioka_2013 |
Section II. Transcriptome annotation
基因ral gene expression (GTEx)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/PIAS1_DE_GTEx.png)
基因expression during devlopment (BrainCloud)
脚注:
总共绘制了269个时间点,n = 38个胎儿样品(x = 1:38)。每个三角形代表一个时间点。
基因expression of temporal and spatial changes (BrainSpan)
脚注:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
基因 | Pearson's Correlation | Spearman's Correlation |
PHF23 | 0.82 | 0.85 |
TMED9 | 0.81 | 0.82 |
ADRM1 | 0.79 | 0.82 |
TIMM22 | 0.79 | 0.79 |
CTNNBIP1 | 0.79 | 0.82 |
R3HCC1 | 0.79 | 0.79 |
POLR2E | 0.79 | 0.80 |
SAMM50 | 0.79 | 0.80 |
GRWD1 | 0.79 | 0.82 |
VPS4A | 0.79 | 0.81 |
前10个负共表达基因 | ||
基因 | Pearson's Correlation | Spearman's Correlation |
MT-CO2 | -0.70 | -0.73 |
AF347015.31 | -0.70 | -0.71 |
AF347015.2 | -0.68 | -0.74 |
AF347015.8 | -0.68 | -0.72 |
MT-CYB | -0.67 | -0.71 |
AF347015.33 | -0.67 | -0.70 |
AF347015.15 | -0.66 | -0.71 |
AF347015.27 | -0.65 | -0.70 |
AF347015.21 | -0.64 | -0.67 |
AF347015.9 | -0.61 | -0.69 |
第四节。蛋白质蛋白相互作用注释
Interactors | Aliases B | Official full name B | Experimental | 资源 | PubMed ID |
---|---|---|---|---|---|
AR | AIS |DHTR |Humara |KD |NR3C4 |SBMA |smax1 |TFM | androgen receptor | - | HPRD | 11877418 |
AR | AIS |DHTR |Humara |KD |NR3C4 |SBMA |smax1 |TFM | androgen receptor | 两个杂交 | BioGRID | 11117529 |
axin1 | AXIN | MGC52315 | axin 1 | - | HPRD | 12223491 |
CASP8 | ALPS2B | CAP4 | FLICE | FLJ17672 | MACH | MCH5 | MGC78473 | caspase 8,与凋亡相关的半胱氨酸肽酶 | CASP8(caspase-8)与PIAS-1相互作用。 | BIND | 15782135 |
CEBPA | C/EBP-alpha | CEBP | CCAAT/enhancer binding protein (C/EBP), alpha | C/EBP-alpha interacts with PIAS1. | BIND | 15588942 |
CEBPE | C/EBP-epsilon | CRP1 | CCAAT/enhancer binding protein (C/EBP), epsilon | C/EBP-epsilon interacts with PIAS1. | BIND | 15588942 |
CEBPE | C/EBP-epsilon | CRP1 | CCAAT/enhancer binding protein (C/EBP), epsilon | - | HPRD | 15588942 |
CSRP2 | CRP2 | LMO5 | SmLIM | cysteine and glycine-rich protein 2 | CRP2 interacts with PIAS1. | BIND | 11672422 |
CSRP2 | CRP2 | LMO5 | SmLIM | cysteine and glycine-rich protein 2 | - | HPRD,Biogrid | 11672422 |
dclre1a | KIAA0086 | PSO2 | SNM1 | SNM1A | hSNM1 | DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae) | - | HPRD | 15572677 |
DDX21 | DKFZp686F21172 | GUA | GURDB | RH-II/GU | RH-II/GuA | DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 | - | HPRD | 9177271 |
DNM1 | DNM | Dynamin 1 | - | HPRD | 15123615 |
DNMT3A | DNMT3A2 |M.Hsaiiia | DNA(胞嘧啶-5-) - 甲基转移酶3αα | - | HPRD,Biogrid | 14752048 |
ELK3 | ERP | NET | SAP2 | ELK3,ETS域蛋白(SRF辅助蛋白2) | - | HPRD | 15580297 |
ESR1 | DKFZP686N23123 |er |ESR |Esra |时代|NR3A1 | 雌激素受体1 | ER-alpha interacts with PIAS1. | BIND | 15666801 |
ESR1 | DKFZP686N23123 |er |ESR |Esra |时代|NR3A1 | 雌激素受体1 | - | HPRD | 15666801 |
JUN | AP-1 | AP1 | c-Jun | Jun Oncogene | - | HPRD | 11867732 |
MDM2 | HDMX | MGC71221 | hdm2 | Mdm2 p53 binding protein homolog (mouse) | - | HPRD | 12393906 |
NR2F2 | arp1 |COUP-TFII |couptfb |MGC117452 |SVP40 |TFCOUP2 | nuclear receptor subfamily 2, group F, member 2 | - | HPRD | 15611122|15666827 |
NR3C2 | MCR |MGC133092 |MLR |先生 | nuclear receptor subfamily 3, group C, member 2 | - | HPRD | 14500761 |
PIAS2 | MGC102682 | MIZ1 | PIASX | PIASX-ALPHA | PIASX-BETA | SIZ2 | ZMIZ4 | miz | 活化统计的蛋白质抑制剂2 | - | HPRD | 11877418 |
PIAS4 | FLJ12419 |MGC35296 |Piasy |piasg |ZMIZ6 | protein inhibitor of activated STAT, 4 | - | HPRD | 11877418 |
PTK2 | FADK | FAK | FAK1 | pp125FAK | PTK2蛋白酪氨酸激酶2 | - | HPRD | 14500712 |
Rela | MGC131774 | NFKB3 | p65 | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | - | HPRD | 15657437 |
SATB2 | FLJ21474 |FLJ32076 |KIAA1034 |MGC119474 |MGC119477 | SATB homeobox 2 | - | HPRD | 14701874 |
SP100 | DKFZp686E07254 | FLJ00340 | FLJ34579 | SP100 nuclear antigen | Biochemical Activity | BioGRID | 18691969 |
SP3 | DKFZP686O1631 |SPR-2 | SP3转录因子 | - | HPRD,Biogrid | 12356736 |
STAB2 | DKFZP434E0321 |Feel-2 |Fele-2 |跌倒|FLEL-2 |fex2 |野兔|Stab-2 | stabilin 2 | Affinity Capture-Western | BioGRID | 14701874 |
STAT1 | DKFZp686B04100 | ISGF-3 | STAT91 | signal transducer and activator of transcription 1, 91kDa | - | HPRD,Biogrid | 9724754|10805787 |12855578|10805787 |
STAT1 | DKFZp686B04100 | ISGF-3 | STAT91 | signal transducer and activator of transcription 1, 91kDa | - | HPRD | 9724754|10805787 |12855578 |
SUFU | PRO1280 | SUFUH | SUFUXL | suppressor of fused homolog (Drosophila) | - | HPRD | 14611647 |
SUMO1 | DAP-1 | GMP1 | OFC10 | PIC1 | SENP2 | SMT3 | SMT3C | SMT3H3 | SUMO-1 | UBL1 | SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) | SUMO-1 interacts with PIAS1. | BIND | 14609633 |
SUMO1 | DAP-1 | GMP1 | OFC10 | PIC1 | SENP2 | SMT3 | SMT3C | SMT3H3 | SUMO-1 | UBL1 | SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) | - | HPRD,Biogrid | 11583632 |
TP53 | FLJ92943 |LFS1 |trp53 |p53 | tumor protein p53 | Biochemical Activity Reconstituted Complex 两个杂交 |
BioGRID | 10380882|11583632 |
TP53 | FLJ92943 |LFS1 |trp53 |p53 | tumor protein p53 | PIAS1 interacts with p53. This interaction was modeled on a demonstrated interaction between human PIAS1 and p53 from an unspecified species. | BIND | 15133049 |
TP53 | FLJ92943 |LFS1 |trp53 |p53 | tumor protein p53 | - | HPRD | 11583632|11788578 |11867732|15133049 |
ube2i | C358B7.1 |P18 |UBC9 | 泛素结合酶E2I(UBC9同源物,酵母) | Ubc9 interacts with PIAS1. | BIND | 14609633 |
ube2i | C358B7.1 |P18 |UBC9 | 泛素结合酶E2I(UBC9同源物,酵母) | - | HPRD | 12177000 |
ube2i | C358B7.1 |P18 |UBC9 | 泛素结合酶E2I(UBC9同源物,酵母) | Reconstituted Complex 两个杂交 |
BioGRID | 11583632|12356736 |14609633 |
V.途径注释
Pathway name | Pathway size | #szgr 2.0基因 | Info |
---|---|---|---|
KEGG UBIQUITIN MEDIATED PROTEOLYSIS | 138 | 98 | 该途径中的所有SZGR 2.0基因 |
KEGG JAK STAT SIGNALING PATHWAY | 155 | 105 | 该途径中的所有SZGR 2.0基因 |
KEGG PATHWAYS IN CANCER | 328 | 259 | 该途径中的所有SZGR 2.0基因 |
KEGG SMALL CELL LUNG CANCER | 84 | 67 | 该途径中的所有SZGR 2.0基因 |
ST JAK STAT PATHWAY | 9 | 8 | 该途径中的所有SZGR 2.0基因 |
PID AR PATHWAY | 61 | 46 | 该途径中的所有SZGR 2.0基因 |
PID TCPTP途径 | 43 | 33 | 该途径中的所有SZGR 2.0基因 |
PID RANBP2途径 | 11 | 11 | 该途径中的所有SZGR 2.0基因 |
PID IFNG途径 | 40 | 34 | 该途径中的所有SZGR 2.0基因 |
PID IL6 7 PATHWAY | 47 | 40 | 该途径中的所有SZGR 2.0基因 |
PID刺猬Gli途径 | 48 | 35 | 该途径中的所有SZGR 2.0基因 |
IFNG信号的Reactome调节 | 14 | 10 | 该途径中的所有SZGR 2.0基因 |
Reactome干扰素伽马信号传导 | 63 | 48 | 该途径中的所有SZGR 2.0基因 |
REACTOME INTERFERON SIGNALING | 159 | 116 | 该途径中的所有SZGR 2.0基因 |
Reactome免疫系统 | 933 | 616 | 该途径中的所有SZGR 2.0基因 |
免疫系统中的反应组细胞因子信号传导 | 270 | 204 | 该途径中的所有SZGR 2.0基因 |
家长mtor信号向上 | 567 | 375 | 该途径中的所有SZGR 2.0基因 |
DAVICIONI MOLECULAR ARMS VS ERMS UP | 332 | 228 | 该途径中的所有SZGR 2.0基因 |
WANG RESPONSE TO ANDROGEN UP | 29 | 21 | 该途径中的所有SZGR 2.0基因 |
WANG RESPONSE TO FORSKOLIN DN | 9 | 7 | 该途径中的所有SZGR 2.0基因 |
Basaki YBX1靶向DN | 384 | 230 | 该途径中的所有SZGR 2.0基因 |
奥斯曼膀胱癌 | 404 | 246 | 该途径中的所有SZGR 2.0基因 |
RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED DN | 805 | 505 | 该途径中的所有SZGR 2.0基因 |
血清剥夺的Graessmann凋亡 | 552 | 347 | 该途径中的所有SZGR 2.0基因 |
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN DN | 584 | 395 | 该途径中的所有SZGR 2.0基因 |
Schaeffer前列腺开发48小时 | 487 | 286 | 该途径中的所有SZGR 2.0基因 |
AMIT DELAYED EARLY GENES | 18 | 15 | 该途径中的所有SZGR 2.0基因 |
BENPORATH MYC MAX TARGETS | 775 | 494 | 该途径中的所有SZGR 2.0基因 |
AMIT EGF RESPONSE 40 HELA | 42 | 29 | 该途径中的所有SZGR 2.0基因 |
尼尔森对雄激素的反应 | 86 | 61 | 该途径中的所有SZGR 2.0基因 |
BLALOCK ALZHEIMERS DISEASE DN | 1237 | 837 | 该途径中的所有SZGR 2.0基因 |
击倒卡路里限制肌肉DN | 87 | 59 | 该途径中的所有SZGR 2.0基因 |
SESTO RESPONSE TO UV C1 | 72 | 45 | 该途径中的所有SZGR 2.0基因 |
BILD HRAS ONCOGENIC SIGNATURE | 261 | 166 | 该途径中的所有SZGR 2.0基因 |
DURCHDEWALD SKIN CARCINOGENESIS DN | 264 | 168 | 该途径中的所有SZGR 2.0基因 |
MONNIER POSTRADIATION TUMOR ESCAPE DN | 373 | 196 | 该途径中的所有SZGR 2.0基因 |
MARSON BOUND BY E2F4 UNSTIMULATED | 728 | 415 | 该途径中的所有SZGR 2.0基因 |
STEARMAN LUNG CANCER EARLY VS LATE UP | 125 | 89 | 该途径中的所有SZGR 2.0基因 |
阿塞维多肝癌 | 973 | 570 | 该途径中的所有SZGR 2.0基因 |
DANG BOUND BY MYC | 1103 | 714 | 该途径中的所有SZGR 2.0基因 |
PILON KLF1 TARGETS DN | 1972年 | 1213 | 该途径中的所有SZGR 2.0基因 |
BRUINS UVC RESPONSE VIA TP53 GROUP B | 549 | 316 | 该途径中的所有SZGR 2.0基因 |